Tuesday 5 July 2016

Spotlight on Pseudomonas aeruginosa

Pseudomonas aeruginosa is a major cause of hospital-acquired infections. This bacterium presents a public health concern due to the high rate of morbidity and mortality that it leaves in its dark path. Additionally, P. aeruginosa is highly resistant to antibiotics for many reasons, such as acquiring resistance genes or constitutively expressing β-lactamases and efflux pumps. A new mini-review features new therapeutic approaches for combating drug resistant P. aeruginosa infections.

To understand an organism’s reaction to a drug or family of drugs, researchers must know which genes act on which set of drug compounds. Are you looking for a simple way to detect and profile antibiotic resistance genes in your bacteria samples?

This is the subject of a report from the Microbiome Research Group, which can be accessed here.

Posted by Dr. Tim Sandle

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers